News items related to: Argentina
-
FGEP Files Pre-Grant Patent Opposition for Covid Vaccine Against Pfizer
Fundación Grupo Efecto Positivo (FGEP) has filed a pre-grant patent opposition in a bid to make COVID-19 vaccines accessible and...
-
The pandemic is declared finished, but the fight for access never stops
MMA consortium members from Argentina, Brazil, Thailand and EECA region, took action to secure access to molnupiravir. In Argentina, the...
-
‘Held to ransom’: Pfizer demands governments gamble with state assets to secure vaccine deal
Pfizer has been accused of “bullying” Latin American governments in COVID-19 vaccine negotiations and has asked some countries to put...
-
AIDS 2020 leadership workshop: Strategies for lowering drug prices
Activists, policy-makers, researchers and healthcare providers joined a leadership workshop led by ITPC’s Make Medicines Affordable campaign at AIDS 2020...
-
COVID-19: Another of Gilead’s FIVE patent applications on remdesivir is opposed in Argentina
Our campaign partner, Fundación GEP, has filed a second patent opposition against one of Gilead’s numerous patent applications for the...
-
Argentina: Fundación GEP opposes Gilead’s patent application on remdesivir
Our partner, Fundación GEP, has filed a patent opposition against Gilead’s patent application on remdesivir before the Argentinean Patent Office....
-
IN PHOTOS: Make Medicines Affordable – for all
Millions of people die unnecessarily each year because life-saving medicines are overpriced. Tactics often employed by pharmaceutical companies keep prices...
-
Removing barriers to affordable treatment: Communities at the centre
The work of our campaign partner in Argentina, Fundación Grupo Efecto Positivo (FGEP), has been documented in UNAIDS’ Global AIDS...
-
The EU-Mercosur trade deal: Will it go up in flames before it’s ratified?
After 20 years, political agreement has been reached on a free trade agreement (FTA) between the EU and the South...
-
Activists fear looming health crisis in Argentina – call on IMF to act
Today global health activists took to the streets in Washington DC to highlight the looming health crisis facing the people...
-
Fundación GEP opposes patent on HIV drug Tenofovir (TAF) in Argentina
Pharmaceutical patent would block access to HIV medicines. Our partner is opposing the patent application in a bid to make...
-
Infographic: How civil society action led to price reductions in Argentina
Civil society action means 27,000 more people could receive HIV treatment for 10 years. The price of 2 key HIV...